Professional Documents
Culture Documents
Printed by: Dang Van Vu Official Date: Official as of 01-Jan-2021 Document Type: USP @2023 USPC
Do Not Distribute DOI Ref: 37uvj DOI: https://doi.org/10.31003/USPNF_M32760_05_01
1
al
IDENTIFICATION Resolution: NLT 1.2 between fentanyl and fentanyl
• A. SPECTROSCOPIC IDENTIFICATION TESTS á197ñ, Infrared related compound E peaks, System suitability solution
Spectroscopy: 197K or 197A Tailing factor: 0.5–2.0, Standard solution
• B. The retention time of the major peak of the Sample Relative standard deviation: NMT 0.73%, Standard
solution corresponds to that of the Standard solution, as solution
obtained in the Assay. Analysis
ASSAY
• PROCEDURE
Solution A: Add 3 mL of triethylamine to about 950 mL of
ci Samples: Standard solution and Sample solution
Calculate the percentage of fentanyl (C22H28N2O) in the
portion of Fentanyl taken:
water in a 1000-mL volumetric flask. Adjust with perchloric Result = (rU/rS) × (CS/CU) × 100
ffi
acid to a pH of 2.62 ± 0.02, and dilute with water to
volume. rU = peak response of fentanyl from the Sample
Solution B: Acetonitrile solution
Diluent: Solution A and Solution B (9:1) rS = peak response of fentanyl from the Standard
Mobile phase: See Table 1. solution
CS = concentration of USP Fentanyl RS in the Standard
O
https://online.uspnf.com/uspnf/document/1_GUID-C0933C5C-368A-4492-BC41-930252AE330A_5_en-US 1/2
www.webofpharma.com
Printed on: Wed Feb 08 2023, 11:48:48 PM(EST) Status: Currently Official on 09-Feb-2023 DocId: GUID-C0933C5C-368A-4492-BC41-930252AE330A_5_en-US
Printed by: Dang Van Vu Official Date: Official as of 01-Jan-2021 Document Type: USP @2023 USPC
Do Not Distribute DOI Ref: 37uvj DOI: https://doi.org/10.31003/USPNF_M32760_05_01
2
Diluent: 0.025% trifluoroacetic acid in a mixture of rS = peak response of fentanyl related compound G
acetonitrile and water (5:95) from the Standard solution
Sensitivity solution: 0.5 µg/mL of USP Fentanyl RS CS = concentration of USP Fentanyl Related
prepared as follows. Transfer a suitable amount of USP Compound G RS in the Standard solution
Fentanyl RS to an adequate volumetric flask. Dissolve in (mg/mL)
10% of final volume using acetonitrile. Sonicate to dissolve, CU = concentration of Fentanyl in the Sample solution
if necessary. Dilute with Diluent to volume. (mg/mL)
Standard solution: 2.0 µg/mL each of USP Fentanyl Related F = relative response factor (see Table 3)
Compound E RS and USP Fentanyl Related Compound G
RS prepared as follows. Transfer suitable amounts of USP Acceptance criteria: See Table 3. The reporting threshold is
Fentanyl Related Compound E RS and USP Fentanyl Related 0.05%.
Compound G RS to an adequate volumetric flask. Dissolve
in 10% of final volume using acetonitrile. Sonicate to Table 3
dissolve, if necessary. Dilute with Diluent to volume. Relative Relative Acceptance
Sample solution: 1.0 mg/mL of Fentanyl prepared as Retention Response Criteria,
follows. Transfer a suitable amount of Fentanyl to an Name Time Factora NMT (%)
adequate volumetric flask. Dissolve in 10% of final volume Fentanyl
using acetonitrile. Sonicate to dissolve, if necessary. Dilute N-oxideb 0.26 0.69 0.15
with Diluent to volume.
Fentanyl related
Chromatographic system compound G 0.78 1.0 0.15
(See Chromatography á621ñ, System Suitability.)
Mode: LC Fentanyl pyruvyl
Detector: UV 240 nm analogc 0.92 3.0 0.15
al
Column: 4.6-mm × 15-cm; 3.5-µm packing L1 Fentanyl 1.00 — —
Column temperature: 45°
Fentanyl related
Flow rate: 1.0 mL/min compound E 1.14
—
0.15
Injection volume: 40 µL
System suitability Fentanyl butyryl
Samples: Sensitivity solution and Standard solution
Suitability requirements
Relative standard deviation: NMT 5.0%, Standard
ci analogd
Any unspecified
impurity
1.21
—
1.5
1.0
0.15
0.10
solution Total impurities — — 0.50
Signal-to-noise ratio: NLT 10, Sensitivity solution
ffi
Analysis a The relative response factor is calculated against fentanyl related compound G.
Samples: Standard solution and Sample solution b 1-Phenethyl-4-(N-phenylpropionamido)piperidine 1-oxide.
Calculate the percentage of fentanyl related compound E c 2-Oxo-N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide.
in the portion of Fentanyl taken: d N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide.
https://online.uspnf.com/uspnf/document/1_GUID-C0933C5C-368A-4492-BC41-930252AE330A_5_en-US 2/2
www.webofpharma.com